PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32468212-1	2020	PURPOSE: To identify gadoxetate disodium-enhanced MRI features distinguishing hepatic IPT from CLM.	gadolinium ethoxybenzyl DTPA	21-40	tRNA isopentenyltransferase 1	Homo sapiens	86-89	
32468212-7	2020	CONCLUSION: Central hypointensity with a relatively peripheral hyperintensity on HBP and SIRlesion/liver on HBP and DWI may be reliable gadoxetate disodium-enhanced MRI features for distinguishing IPT from CLM.	gadolinium ethoxybenzyl DTPA	136-146	tRNA isopentenyltransferase 1	Homo sapiens	197-200